Third-party Funding

Ongoing projects

Funding agencyProject
SFB 1243
"Cancer Evolution: Genetic and Epigenetic Evolution of Hematopoietic Neoplasms"
Funded by DFG (2016-2019)
"Generation of the CanPath prototype - a platform for predictive cancer pathway modelling"
Funded by EU-Horizon2020 (2016-2021)
EraNet EracoSysMed - SysAFib
"Systems medicine for diagnosis and stratification of atrial fibrillation"
Funded by EU-Horizon2020 (2016-2019)
"Liver Systems Medicine"
Funded by BMBF (2016-2018)
"Methods for integrated analysis of multiple omics datasets"
Funded by EU (2012-2017)
e:Med - AtheroMed
"Systems medicine of myocardial infarction and stroke"
Funded by BMBF (2013-2016)
e:Med - IntegraMent
"Integrated, systems-based approach for pathway analysis in psychiatric disease"
Funded by BMBF (2014-2016)
e:Med - SYS-Stomach
"Identification of predictive response and resistance factors to targeted therapy in gastric cancer using a systems medicine approach"
Funded by BMBF (2014-2017)
Mixed Models in Cell Communication and Cancer
(SPP 1395, InKoMBio)

"Generic concepts and information theoretic principles in cell-cell communication"
Funded by DFG (2014-2016)
Stem Cell Genealogies
"Inference of differentiation decisions from stem cell genealogies"
Funded by DFG  (2014-2016)
QBM - Quantitative Biosciences Munich
The Graduate School is a joint initiative by leading scientists from the Ludwig-Maximilians-University Munich, the Max-Planck Institute of Biochemistry, and the Helmholtz Center Munich
"Quantification of regulatory mechanisms on the transcriptional level based on time-lapse microscopy of differentiating stem cells"
Funded by Bavarian Research Network for Molecular Biosystems (2009-2017)